Patents by Inventor Geltrude Mingrone

Geltrude Mingrone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220169709
    Abstract: The present invention relates to an association of inhibitors of the activity of at least one protein belonging to the Hsp70 family and of inhibitors of the GRP78 activity for use in the treatment of insulin resistance and/or of the pathologies deriving from this clinical condition.
    Type: Application
    Filed: March 4, 2020
    Publication date: June 2, 2022
    Applicant: GHP SCIENTIFIC LIMITED
    Inventor: Geltrude MINGRONE
  • Publication number: 20150125426
    Abstract: A composition comprising medium chain dicarboxylic acids and/or derivatives of medium chain dicarboxylic acids can be used to treat or prevent metabolic disorders. The composition can particularly well be used to treat or prevent hyperglycemia, for example diabetes.
    Type: Application
    Filed: January 9, 2015
    Publication date: May 7, 2015
    Inventors: Geltrude Mingrone, Catherine Mace
  • Patent number: 8962689
    Abstract: The present invention relates in general to medium chain dicarboxylic acids, their derivatives and their uses. In particular, the present invention relates to a composition comprising medium chain dicarboxylic acids and to the use of medium chain dicarboxylic acids and their derivatives for the preparation of products to treat or prevent metabolic disorders. The composition of the present invention can particularly well be used to treat or prevent hyperglycemia, for example diabetes.
    Type: Grant
    Filed: March 9, 2009
    Date of Patent: February 24, 2015
    Assignee: Nestec S.A.
    Inventors: Geltrude Mingrone, Catherine Mace
  • Publication number: 20110002900
    Abstract: The present invention relates in general to medium chain dicarboxylic acids, their derivatives and their uses. In particular, the present invention relates to a composition comprising medium chain dicarboxylic acids and to the use of medium chain dicarboxylic acids and their derivatives for the preparation of products to treat or prevent metabolic disorders. The composition of the present invention can particularly well be used to treat or prevent hyperglycemia, for example diabetes.
    Type: Application
    Filed: March 9, 2009
    Publication date: January 6, 2011
    Inventors: Geltrude Mingrone, Catherine Mace
  • Patent number: 5272177
    Abstract: Sebacic acid and the pharmacologically acceptable derivatives thereof, such as the novel compounds sodium sebacate and potassium sebacate, the sebacic acid triglyceride and the sodium and potassium salts of the triglyceride are useful for manufacturing pharmaceutical compositions suitable for the enteral and parenteral nutrition.
    Type: Grant
    Filed: January 29, 1992
    Date of Patent: December 21, 1993
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Geltrude Mingrone